News
While Aldis might not return to the wrestling ring, he might bring back a legendary name to the company to take care of the Viper. Aldis could introduce Ken Anderson (FKA Mr. Kennedy) back to the ...
4d
Wrestling Inc. on MSNMatt Hardy Comments On Joe Hendry's WWE WrestleMania Match, Women's Title Three-WayTNA Wrestling's Matt Hardy weighs in on the WWE WrestleMania 41 matches involving Joe Hendry, IYO SKY, Bianca Belair, and ...
Many of WWE's tag teams have become industry-wide icons. Some pair-ups can define the legacies of performers who would ...
3d
Wrestlezone on MSNTriple H Makes WWE Money In the Bank Match OfficialTriple H makes a marquee match for next month’s WWE Money in the Bank premium live event official. During the closing moments ...
3d
Wrestling Inc. on MSNTriple H Recalls Kevin Nash's Indecision About Leaving WWE For WCWTriple H recalls his good friend Kevin Nash's indecision whether to stay with WWE or join WCW during the early stages of the ...
1don MSN
Tyrese Haliburton had 32 points, 15 assists and 12 assists and 0 turnovers in the Pacers' 130-121 Game 4 win over the Knicks ...
3d
TheSportster on MSN4 Harsh Realities WWE Fans Need To Accept About The Triple H EraWhile WWE has improved under Triple H's creative vision, new problems have risen that fans are going to have to get used to.
WWE chief content officer and head of creative Triple H has officially confirmed a new PLE for New Orleans after WrestleMania ...
1d
Wrestlezone on MSNAleister Black Breaks Silence on WWE Return Under Triple H & Nick Khan LeadershipAleister Black says coming back to WWE under Triple H and Nick Khan leadership felt like coming home. Black made his return ...
Results from the randomized phase 3 DREAMM-8 study of belantamab mafodotin plus pomalidomide and dexamethasone (BPd) vs pomalidomide plus bortezomib and dexamethasone (PVd) in relapsed/refractory ...
Triple H trashes Vince’s rules, reviving the piledriver, loosening promos, and boosting physicality for a thrilling, ...
A first-in-human phase 1, multicenter, open-label study of CB-011, a next-generation CRISPR-genome edited allogeneic anti-BCMA immune-cloaked CAR-T cell therapy, in patients with relapsed/refractory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results